Target: CD19.
Clone: SJ25-C1.
Specificity: Anti-CD19 In Vivo Antibody - Low Endotoxin (SJ25-C1) recognizes an epitope on Human CD19.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Antigen Distribution: Anti-Human CD19 recognizes a (Mr 90 kDa) B-cell surface glycoprotein which is present at all stages of maturation. Anti-CD19 does not react with T-cells, granulocytes, monocytes, erythrocytes or platelets. The CD19 antigen is expressed on approximately 5-25% of human peripheral blood lymphocytes and approximately 60% of splenic lymphocytes.
Immunogen: NALM1 + NALM16 cells.
Concentration: ≥ 2.0 mg/ml.
Formulation: 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purity: >95% by SDS-PAGE and HPLC.
Endotoxin: <0.5 EU/mg as determined by the LAL method.
Aggregation: Aggregation level ≤ 5%.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
English
Deutsch
